Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Encompass Health CorpEHC · Entity 3460 | Director | April 18, 2022 | April 20, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Encompass Health Corp
Report date April 18, 2022 · Filed April 20, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Encompass Health Common StockSEC Table I · non-derivative | Direct | 82,981 |
Reported balance
After 2022-04-18 transaction · row 1
1 source rowRow 1 · 2022-04-18 · Grant · Acquired 298 · Balance 82,981 F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BOB EVANS FARMS INC
Report date January 12, 2018 · Filed January 17, 2018
Section 16 reporting ended · disclosed 2018-01-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock $.01 Par ValueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-01-12 transaction · row 1
1 source rowRow 1 · 2018-01-12 · Disposition to issuer · Disposed 9,497 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of September 18, 2017 (the Merger Agreement), by and among Bob Evans Farms, Inc. (the Company), Post Holdings, Inc. (Post) and Haystack Corporation, a wholly-owned subsidiary of Post at the effective time of the merger, these shares of Company common stock were converted into the right to receive a cash payment (without interest and subject to applicable withholding taxes) equal to the per share merger consideration of $77.00. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-01-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-01-12 · Disposition to issuer · Disposed 774.6877 · Balance 0 F2: Pursuant to the Merger Agreement, at the effective time of the merger, as a result of the Companys determination to cancel the Companys deferred compensation plans, each of these shares of phantom stock were cancelled in exchange for the right to receive a cash payment (without interest and subject to applicable withholding taxes) equal to the per share merger consideration of $77.00. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of September 18, 2017 (the Merger Agreement), by and among Bob Evans Farms, Inc. (the Company), Post Holdings, Inc. (Post) and Haystack Corporation, a wholly-owned subsidiary of Post at the effective time of the merger, these shares of Company common stock were converted into the right to receive a cash payment (without interest and subject to applicable withholding taxes) equal to the per share merger consideration of $77.00.
F2: Pursuant to the Merger Agreement, at the effective time of the merger, as a result of the Companys determination to cancel the Companys deferred compensation plans, each of these shares of phantom stock were cancelled in exchange for the right to receive a cash payment (without interest and subject to applicable withholding taxes) equal to the per share merger consideration of $77.00.
Enhabit, Inc.
Report date May 15, 2026 · Filed May 15, 2026
Section 16 reporting ended · disclosed 2026-05-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,412 |
Reported balance
After 2026-05-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-15 · Disposition to issuer · Disposed 7,226 · Balance 73,412 F1: Pursuant to the Agreement and Plan of Merger ('Merger Agreement'), dated as of February 22, 2026, by and among Enhabit, Inc. (the 'Company'), Anchor Parent, LLC ('Parent'), and Anchor Merger Sub, Inc., a wholly owned subsidiary of Parent ('Merger Sub'), Merger Sub will be merged with and into the Company (the 'Merger'), with the Company surviving the Merger as a wholly owned subsidiary of Parent (the 'Surviving Corporation'). At the effective time of the Merger (the 'Effective Time'), each share of the Company's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $13.80 in cash (the 'Merger Consideration'). |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-05-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-05-15 · Disposition to issuer · Disposed 73,412 · Balance 0 F2: Represents deferred stock units ('DSUs'). Each DSU represents a contingent right to receive one share of common stock of the Company. Pursuant to the Merger Agreement, each DSU that was outstanding as of immediately prior to the Effective Time, was automatically canceled and converted into the right to receive the Merger Consideration, without interest less applicable taxes and withholding. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger ('Merger Agreement'), dated as of February 22, 2026, by and among Enhabit, Inc. (the 'Company'), Anchor Parent, LLC ('Parent'), and Anchor Merger Sub, Inc., a wholly owned subsidiary of Parent ('Merger Sub'), Merger Sub will be merged with and into the Company (the 'Merger'), with the Company surviving the Merger as a wholly owned subsidiary of Parent (the 'Surviving Corporation'). At the effective time of the Merger (the 'Effective Time'), each share of the Company's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $13.80 in cash (the 'Merger Consideration').
F2: Represents deferred stock units ('DSUs'). Each DSU represents a contingent right to receive one share of common stock of the Company. Pursuant to the Merger Agreement, each DSU that was outstanding as of immediately prior to the Effective Time, was automatically canceled and converted into the right to receive the Merger Consideration, without interest less applicable taxes and withholding.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 15, 2026 16:27 UTC | Enhabit, Inc. EHAB · Entity 46765 | Disposition to issuerCommon Stock | 73,412 | $13.80 | $1,013,085.60 |
DisclosureSEC source: 0001122124-26-000006 · wk-form4_1778862428.xml · nonDerivative · entry 2 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · security: Represents deferred stock units ('DSUs'). Each DSU represents a contingent right to receive one share of common stock of the Company. Pursuant to the Merger Agreement, each DSU that was outstanding as of immediately prior to the Effective Time, was automatically canceled and converted into the right to receive the Merger Consideration, without interest less applicable taxes and withholding. Read SEC document |
| May 15, 2026 Filed May 15, 2026 16:27 UTC | Enhabit, Inc. EHAB · Entity 46765 | Disposition to issuerCommon Stock | 7,226 | $13.80 | $99,718.80 |
DisclosureSEC source: 0001122124-26-000006 · wk-form4_1778862428.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,412 F1 · security: Pursuant to the Agreement and Plan of Merger ('Merger Agreement'), dated as of February 22, 2026, by and among Enhabit, Inc. (the 'Company'), Anchor Parent, LLC ('Parent'), and Anchor Merger Sub, Inc., a wholly owned subsidiary of Parent ('Merger Sub'), Merger Sub will be merged with and into the Company (the 'Merger'), with the Company surviving the Merger as a wholly owned subsidiary of Parent (the 'Surviving Corporation'). At the effective time of the Merger (the 'Effective Time'), each share of the Company's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $13.80 in cash (the 'Merger Consideration'). Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 13:50 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 1,340 | $13.99 | $18,746.60 |
DisclosureSEC source: 0001122124-26-000004 · wk-form4_1776088206.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,638 F1 · shares: Represents deferred stock units acquired in lieu of a cash retainer fee at the election of the Reporting Person pursuant to the Enhabit, Inc. Deferred Director Compensation Plan. Read SEC document |
| January 10, 2026 Filed Jan 13, 2026 01:48 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 1,881 | $9.97 | $18,753.57 |
DisclosureSEC source: 0001122124-26-000002 · wk-form4_1768268878.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,298 F1 · shares: Represents deferred stock units acquired in lieu of a cash retainer fee at the election of the Reporting Person pursuant to the Enhabit, Inc. Deferred Director Compensation Plan. Read SEC document |
| October 10, 2025 Filed Oct 10, 2025 21:18 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 2,344 | $8.00 | $18,752.00 |
DisclosureSEC source: 0001122124-25-000003 · wk-form4_1760131128.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,417 Read SEC document |
| July 10, 2025 Filed Jul 10, 2025 21:22 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 2,579 | $7.27 | $18,749.33 |
DisclosureSEC source: 0001803737-25-000139 · wk-form4_1752182520.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,073 F1 · shares: Represents deferred stock units acquired in lieu of a cash retainer fee at the election of the Reporting Person pursuant to the Enhabit, Inc. Deferred Director Compensation Plan. Read SEC document |
| June 26, 2025 Filed Jun 27, 2025 20:16 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 15,773 | $9.51 | $150,001.23 |
DisclosureSEC source: 0001628280-25-033324 · wk-form4_1751055369.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,494 Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 12:46 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 2,335 | $8.03 | $18,750.05 |
DisclosureSEC source: 0001803737-25-000076 · wk-form4_1744375565.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,721 F1 · shares: Represents deferred stock units acquired in lieu of a cash retainer fee at the election of the Reporting Person pursuant to the Enhabit, Inc. Deferred Director Compensation Plan. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 13:27 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 2,404 | $7.80 | $18,751.20 |
DisclosureSEC source: 0001803737-25-000019 · wk-form4_1736515624.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,386 F1 · shares: Represents deferred stock units acquired in lieu of a cash retainer fee at the election of the Reporting Person pursuant to the Enhabit, Inc. Deferred Director Compensation Plan. Read SEC document |
| October 10, 2024 Filed Oct 15, 2024 10:19 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 2,633 | $7.12 | $18,746.96 |
DisclosureSEC source: 0001803737-24-000177 · wk-form4_1728987539.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,982 F1 · shares: Represents deferred stock units acquired in lieu of a cash retainer fee at the election of the Reporting Person pursuant to the Enhabit, Inc. Deferred Director Compensation Plan. Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 21:20 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 14,578 | $10.29 | $150,007.62 |
DisclosureSEC source: 0001803737-24-000141 · wk-form4_1722288032.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,349 Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 18:06 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 12,702 | $11.81 | $150,010.62 |
DisclosureSEC source: 0001803737-23-000127 · wk-form4_1688148406.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,771 Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 22:54 UTC | Enhabit, Inc. EHAB · Entity 46765 | PurchaseCommon Stock | 3,700 | $13.55 | $50,135.00 |
DisclosureSEC source: 0001803737-22-000097 · wf-form4_166060396996981.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,069 F1 · balance_after: The amount of shares of common stock reported in Column 5 is less than previously reported due to the way Encompass Health Corporation restricted stock units were treated in the separation and distribution from Encompass Health Corporation. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 23:16 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 6,597 | $0.00 | $0.00 |
DisclosureSEC source: 0001803737-22-000064 · wf-form4_165714935223442.xml · nonDerivative · entry 3 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,333 Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 23:16 UTC | Enhabit, Inc. EHAB · Entity 46765 | GrantCommon Stock | 8,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001803737-22-000064 · wf-form4_165714935223442.xml · nonDerivative · entry 2 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,736 Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 23:16 UTC | Enhabit, Inc. EHAB · Entity 46765 | OtherCommon Stock | 41,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001803737-22-000064 · wf-form4_165714935223442.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,490 F1 · kind: In connection with the spin-off of Enhabit, Inc. ("Enhabit") by Encompass Health Corporation ("Encompass") on June 30, 2022, Encompass distributed all of the issued and outstanding shares of Enhabit common stock to Encompass stockholders (the "Distribution"). Encompass stockholders received one share of Enhabit common stock for every two shares of Encompass common stock held as of the close of business on June 24, 2022. The number of shares of Enhabit common stock reported as acquired on this Form 4 reflects the number of shares of Enhabit common stock, including shares of restricted stock, acquired by the reporting person pursuant to the Distribution. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 17:51 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 298 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012240 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,981 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:08 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 343 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001729 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,683 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 13:29 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027252 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,340 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $67.62. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 18:52 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-022096 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,029 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $79.89. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| May 06, 2021 Filed May 10, 2021 16:12 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 1,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-015984 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,766 F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 13:45 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013953 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,009 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:35 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 244 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002086 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,762 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| October 16, 2020 Filed Oct 20, 2020 14:36 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 298 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-027244 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,518 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $68.11. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:05 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021828 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,220 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $65.21. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| May 06, 2020 Filed May 7, 2020 21:39 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 2,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015804 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,911 F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 13:13 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 279 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-013955 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,607 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $69.76. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 14:15 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-001991 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,328 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $77.50. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 15:21 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 298 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030670 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,078 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2019, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $64.71. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 16, 2019 Filed Jul 17, 2019 22:08 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 288 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-024794 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,780 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $64.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| May 03, 2019 Filed May 7, 2019 16:00 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 2,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-017542 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,492 F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 23, 2019 Filed Apr 24, 2019 13:08 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 291 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016096 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,165 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:08 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 269 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-002122 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,874 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 19:58 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-030492 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,605 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2018, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 20:01 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-023480 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,367 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| May 04, 2018 Filed May 7, 2018 20:59 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 2,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016517 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,130 F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 22:26 UTC | Encompass Health Corp EHC · Entity 3460 | GrantHealthsouth Common Stock | 274 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-014892 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,744 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:44 UTC | Encompass Health Corp EHC · Entity 3460 | GrantHealthsouth Common Stock | 303 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-002083 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,470 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 12, 2018 Filed Jan 17, 2018 17:56 UTC | BOB EVANS FARMS INC BOBE · Entity 170259 | Disposition to issuerPhantom Stock · Derivative | 774.6877 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000033769-18-000047 · edgardoc.xml · derivative · entry 2 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock $.01 Par Value · 774.6877 shares Expires not disclosed F2 · derivative.exercise_price: Pursuant to the Merger Agreement, at the effective time of the merger, as a result of the Companys determination to cancel the Companys deferred compensation plans, each of these shares of phantom stock were cancelled in exchange for the right to receive a cash payment (without interest and subject to applicable withholding taxes) equal to the per share merger consideration of $77.00. F2 · price: Pursuant to the Merger Agreement, at the effective time of the merger, as a result of the Companys determination to cancel the Companys deferred compensation plans, each of these shares of phantom stock were cancelled in exchange for the right to receive a cash payment (without interest and subject to applicable withholding taxes) equal to the per share merger consideration of $77.00. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the merger, as a result of the Companys determination to cancel the Companys deferred compensation plans, each of these shares of phantom stock were cancelled in exchange for the right to receive a cash payment (without interest and subject to applicable withholding taxes) equal to the per share merger consideration of $77.00. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, at the effective time of the merger, as a result of the Companys determination to cancel the Companys deferred compensation plans, each of these shares of phantom stock were cancelled in exchange for the right to receive a cash payment (without interest and subject to applicable withholding taxes) equal to the per share merger consideration of $77.00. Read SEC document |
| January 12, 2018 Filed Jan 17, 2018 17:56 UTC | BOB EVANS FARMS INC BOBE · Entity 170259 | Disposition to issuerCommon Stock $.01 Par Value | 9,497 | $77.00 | $731,269.00 |
DisclosureSEC source: 0000033769-18-000047 · edgardoc.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of September 18, 2017 (the Merger Agreement), by and among Bob Evans Farms, Inc. (the Company), Post Holdings, Inc. (Post) and Haystack Corporation, a wholly-owned subsidiary of Post at the effective time of the merger, these shares of Company common stock were converted into the right to receive a cash payment (without interest and subject to applicable withholding taxes) equal to the per share merger consideration of $77.00. Read SEC document |
| October 16, 2017 Filed Oct 18, 2017 15:59 UTC | Encompass Health Corp HLS · Entity 3460 | GrantHealthsouth Common Stock | 344 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-029993 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,167 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2017, HealthSouth paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 17, 2017 Filed Jul 19, 2017 18:51 UTC | Encompass Health Corp HLS · Entity 3460 | GrantHealthsouth Common Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-023859 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,823 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:05 UTC | Encompass Health Corp HLS · Entity 3460 | GrantHealthsouth Common Stock | 3,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-017057 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,501 F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 19:46 UTC | Encompass Health Corp HLS · Entity 3460 | GrantHealthsouth Common Stock | 319 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-015056 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,435 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 19:11 UTC | Encompass Health Corp HLS · Entity 3460 | GrantHealthsouth Common Stock | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-002001 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,116 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 17:56 UTC | Encompass Health Corp HLS · Entity 3460 | GrantHealthsouth Common Stock | 346 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-065002 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,783 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 17, 2016, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.